ORIGINAL RESEARCH article
Front. Digit. Health
Sec. Personalized Medicine
Volume 7 - 2025 | doi: 10.3389/fdgth.2025.1583399
This article is part of the Research TopicArtificial Intelligence in Cardiovascular ResearchView all 5 articles
Interpretable AI-Driven Multi-Objective Risk Prediction in Heart Failure Patients with Thyroid Dysfunction
Provisionally accepted- 1Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Apulia, Italy
- 2Department of Agriculture, Food, Natural Resources and Engineering Sciences, University of Foggia, Foggia, Apulia, Italy
- 3University of Bari Aldo Moro, Bari, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Heart Failure (HF) complicated by thyroid dysfunction presents a complex clinical challenge, demanding more advanced risk stratification tools. In this study, we propose an AI-driven machine learning (ML) approach to predict mortality and hospitalization risk in HF patients with coexisting thyroid disorders. Using a retrospective cohort of 762 HF patients (including euthyroid, hypothyroid, hyperthyroid, and low T3 syndrome cases), we developed and optimized several ML models -including Random Forest, Gradient Boosting, Support Vector Machines, and others -to identify high-risk individuals. The best-performing model, a Random Forest classifier, achieved robust predictive accuracy for both 1-year mortality and HF-related hospitalization (area under the ROC curve ~0.80 for each). We further employed model interpretability techniques (Local Interpretable Model-agnostic Explanations, LIME) to elucidate key predictors of risk at the individual level. This interpretability revealed that factors such as atrial fibrillation, absence of cardiac resynchronization therapy, amiodarone use, and abnormal thyroid-stimulating hormone (TSH) levels strongly influenced model predictions, providing clinicians with transparent insights into each prediction. Additionally, a multi-objective risk stratification analysis across thyroid status subgroups highlighted that patients with hypothyroidism and low T3 syndrome are particularly vulnerable under high-risk conditions, indicating a need for closer monitoring and tailored interventions in these groups. In summary, our study demonstrates an innovative AI methodology for medical risk prediction: interpretable ML models can accurately stratify mortality and hospitalization risk in HF patients with thyroid dysfunction, offering a novel tool for personalized medicine. These findings suggest that integrating explainable AI into clinical workflows can improve prognostic precision and inform targeted management, though prospective validation is warranted to confirm real-world applicability.
Keywords: artificial intelligence, machine learning, Heart Failure, thyroid dysfunction, risk stratification, Explainable AI
Received: 26 Feb 2025; Accepted: 29 Apr 2025.
Copyright: © 2025 Iacoviello, Santamato, Pagano and Marengo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Agostino Marengo, Department of Agriculture, Food, Natural Resources and Engineering Sciences, University of Foggia, Foggia, 71122, Apulia, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.